Slow growth in MA health care spending
Partners says nurse ballot question would boost its costs $140m
STATE HOUSE NEWS SERVICE
HEALTH CARE SPENDING in Massachusetts rose 1.6 percent to $61.1 billion in 2017, increasing at the slowest rate tracked since the passage of a 2012 health care cost control law.
The Center for Health Information and Analysis, in its annual report on the performance of the state’s health care system, logged a $1.3 billion increase in total health care expenditures from 2016 to 2017, representing a rate of growth more moderate than the 3 percent recorded the previous year.
The report also flagged continuing concerns about the affordability of care, despite a nation-leading health insurance coverage rate of 96.3 percent.
“Just as a citizen and as a person that works in this space, I’d say 1.6 percent is a number that we should feel really good about,” Campbell told reporters. “That’s not the growth rate that we were experiencing when we started out on this path, so it feels like it represents progress but it also feels like there’s more work to be done.”
Commercial health care spending increased by 3.1 percent to $22.8 billion and Medicare spending increased by 1.9 percent to $17 billion, while MassHealth spending dropped slightly, according to CHIA — a 0.2 percent decline to $17.2 billion. The report attributes the drop in part to a 2.4 percent decrease in MassHealth enrollment.
“As you look at the commercial-Medicare-Medicaid, we should also celebrate the work of Medicaid because that’s usually the number that we see going up and here it’s the place where it’s going down,” said commission member Martin Cohen, the president and CEO of the MetroWest Health Foundation.
Campbell said MassHealth has been “working very hard at controlling the program costs,” but per member per month expenditures still increased despite the overall drop.
“I don’t think there’s any sense that they’ve turned the corner or that they’ve put their cost issues behind them,” Campbell said.
Brendan Moss, a spokesman for Gov. Charlie Baker, said the administration has prioritized “managing down” MassHealth’s growth from “unsustainable” levels, and “is pleased to have saved taxpayers hundreds of millions of dollars by strengthening the program’s internal controls and improving caseload management, while still ensuring nearly universal health coverage for the people of Massachusetts.”
The 2012 cost containment law, which established CHIA, also created an annual benchmark against which medical spending growth is measured. Last year’s 1.6 percent growth rate falls well below the 2017 benchmark of 3.6 percent.
Partners HealthCare, the state’s largest health care company, said on Wednesday that it estimates its costs would go up $140 million if the ballot question passes. The company said costs would go up the most at Massachusetts General Hospital ($34.1 million), but would also increase at Brigham & Women’s ($24.7 million), Newton-Wellesley ($16.4 million), North Shore Medical Center ($19.4 million), and McLean ($10.8 million).
As in 2016, prescription drug spending, which climbed 5 percent to $9.7 billion, and hospital outpatient spending, which rose 4.8 percent to $10.6 billion, continued to be main drivers of cost growth. the report said. Hospital inpatient spending, which experienced a 0.9 percent increase, accounted for the largest portion of total health care expenditures, at $11.2 billion.
Hospital outpatient spending accounted for 38.4 percent of the new spending between 2016 and 2017, and pharmacy spending accounted for 36.5 percent of that $1.3 billion.
Robert Coughlin, president and CEO of the Massachusetts Biotechnology Council, said increases in drug spending “have reached new lows,” down to a 5 percent increase from the 6.4 percent recorded in 2016 and 12 percent in 2015.
“Massachusetts continues to serve as an example for healthcare innovation, both in terms of drug discovery but also in new innovative payment models for these therapies,” Coughlin said. “We’ll continue to work with payers and other stakeholders to ensure patients have access to lifesaving therapies and that our healthcare system can measure the value these drugs bring to patients and in lowering our overall healthcare costs.”Massachusetts Association of Health Plans President Lora Pellegrini said the data highlights the need to address prescription drug pricing and the cost of outpatient hospital services.
“While today’s news demonstrates important progress in bending the cost trend, Massachusetts’ health care costs are still among the highest in the nation, second only to Alaska,” Pellegrini said. “It is essential that all health care stakeholders remain focused on reducing health care costs and improving quality of care for patients.”